About Sykynthor Inc.
By evaluating the "intestinal microflora" of the human body through DNA analysis, the company develops and provides services that contribute to self-care by testing health conditions and lifestyle levels. The "intestinal microflora," a group of microorganisms living in the intestines, is said to have a significant impact on human health in terms of activating physical and immune functions. The company has the largest data collection of samples in Japan in the field of microbiota testing services, and is a startup that is being introduced to medical institutions nationwide and collaborating with major business companies.

Yu Sawai (Representative Director, Saikinso Corporation)
Bacterial flora (intestinal flora) exists in every person's body and plays a variety of roles that are strongly related to one's lifestyle, especially what he/she eats, thereby influencing his/her health condition. We believe that the participation of the "Future of Food Fund," which specializes in food tech, will enhance the utility of intestinal microflora data in the pursuit of personalization and health functions in the "food" field, and will lead to the realization of further growth opportunities for our company. Saikinso will continue to create and promote next-generation healthcare services in order to realize the goal of "making people healthier through bacterial flora.
Hiroki Okada, Managing Partner, Food for the Future Fund (kemuri ventures)
Cykinso has an overwhelming database of 40,000 specimens in the testing of intestinal bacteria, which are closely related to "food," and is highly evaluated by many medical institutions and major business companies. The company has already developed "proprietary algorithms" for the bacterial calculation process and test result output, and I was impressed by the high level of its technological capabilities, including the background of its management team. We also liked the fact that the company offers users "easy-to-understand and inexpensive" proposals on "current health conditions" and "future improvement methods.
We are confident that Saikinsoe will play an important role in the food tech area of "food-induced diseases" and "health/functional foods" by providing evidence data. As a fund specializing in food tech, we will support Saikinso in both management and business aspects.
Company Profile of Saikinso Corporation
| name of company | Saikinso Corporation |
| Establishment | November 2014 |
| Location | 1-36-1 Yoyogi, Shibuya-ku, Tokyo |
| representative | Yu Sawai |
| Business Overview | Development and provision of gut microbiome testing services |
| uniform resouce locator | Development and provision of gut microbiome testing services |
kemuri ventures, LLC Company Profile

| name of company | kemuri ventures, llc |
| Establishment | May 2020 |
| Location | Wakamiya-cho, Shinjuku-ku, Tokyo |
| representative | Hiroki Okada |
| Business Overview | Venture capital business, CVC support business for major business companies |
| uniform resouce locator | https://www.kemuriventures.co.jp |









